Equinix — Oct 29, 2025 release
Fiscal 2025 third-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0001101239-25-000061
Showing in the filing
Revenues
“$2.411 and $2.531 billion”
Period
Q4 FY2025
Measure
GAAP-tied
Source
Prose
All guidance in this release · 24
Revenues for FY2025
“$9,208 - 9,328”
Adjusted EBITDA Margin % for Q4 FY2025
“49 - 50%”
AFFO per Share (Diluted) for FY2025
“$37.95 - 38.77”
Non-recurring Capital Expenditures (includes… for FY2025
“$3,514 - 3,994”
Recurring Capital Expenditures % of revenues for FY2025
“~3%”
Recurring Capital Expenditures % of Revenues for Q4 FY2025
“6%”
Expected Cash Dividends for FY2025
“~$1,836”
Revenues for Q4 FY2025
“$2.411 and $2.531 billion”
Adjusted EBITDA for Q4 FY2025
“$1.187 and $1.267 billion”
Recurring capital expenditures for Q4 FY2025
“$134 and $154 million”
Total revenues for FY2025
“$9.208 and $9.328 billion”
Total revenues growth, as-reported for FY2025
“approximately 5 - 7%”
Total revenues growth, normalized and consta… for FY2025
“approximately 7 - 8%”
Adjusted EBITDA for FY2025
“$4.531 and $4.611 billion”
Adjusted EBITDA margin for FY2025
“49%”
AFFO for FY2025
“$3.731 and $3.811 billion”
AFFO growth, as-reported for FY2025
“11 - 14%”
AFFO growth, normalized and constant currency for FY2025
“11 - 13%”
AFFO per share growth, as-reported for FY2025
“8 - 11%”
AFFO per share growth, normalized and consta… for FY2025
“8 - 10%”
Total capital expenditures for FY2025
“$3.792 and $4.292 billion”
Non-recurring capital expenditures for FY2025
“$3.514 and $3.994 billion”
On-balance-sheet xScale-related spend for FY2025
“approximately $450 million”
Recurring capital expenditures for FY2025
“$278 and $298 million”
Exhibit 99.1 · the passage around this item
… earlier in the release
Equinix intends to calculate the various non-GAAP financial measures in future periods consistent with how they were calculated for the periods presented within this press release. For the fourth quarter of 2025, the company expects revenues to range between $2.411 and $2.531 billion, an increase of 7% at the midpoint over the previous quarter on both an as-reported basis and a normalized and constant currency basis. This guidance includes a $4 million foreign currency benefit when compared to the average FX rates in Q3 2025. Adjusted EBITDA is expected to range between $1.187 and $1.267 billion. This guidance includes a $3 million foreign currency benefit when compared to the average FX rates in Q3 2025. Recurring capital expenditures are expected to range between $134 and $154 million. For the full year of 2025, total revenues are expected to range between $9.208 and $9.328 billion, an as-reported increase of approximately 5 - 7% over the previous year, or a normalized and constant currency increase of approximately 7 - 8%. This updated guidance maintains prior full-year revenue guidance, offset by a $15 million negative foreign currency impact when compared to the prior guidance rates. Adjusted EBITDA is expected to range between $4.531 and $4.611 billion, reflecting an adjusted EBITDA margin of 49%, an approximate 250 basis-point expansion over the previous year. This updated guidance includes an underlying raise of $21 million from better-than-expected bu
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.